Tenet Healthcare Revenue Growth Rates (THC), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Tenet Healthcare Corp  (NYSE: THC)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

THC's Revenue Growth by Quarter and Year

Tenet Healthcare's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

THC Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 5,628.00
1st Quarter March 5,368.00
FY 10,996.00

THCs Annual Revenue
Tenet Healthcare's Revenue in the fiscal year 2025 $ 21,310.00 millions
Tenet Healthcare's Revenue in the fiscal year 2024 $ 20,665.00 millions
Tenet Healthcare's Revenue in the fiscal year 2023 $ 20,548.00 millions
Tenet Healthcare's Revenue in the fiscal year 2022 $ 19,174.00 millions
Tenet Healthcare's Revenue in the fiscal year 2021 $ 19,485.00 millions




THC Revenue second quarter 2026 Y/Y Growth Comment
Tenet Healthcare Corp reported Revenue growth of 6.77% year on year in the second quarter 2026, to $ 5,628.00 millions, this is lower than Tenet Healthcare Corp's recent average Revenue growth of 7.6%.

Looking into second quarter 2026 results within Healthcare Facilities industry 24 other companies have achieved higher Revenue growth. While Tenet Healthcare Corp' s Revenue increase of 6.77% ranks overall at the positon no. 2388 in the second quarter 2026.


THC Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 8.97 % -5.71 % 7.8 %
3rd Quarter September - 3.26 % 1.11 % 5.52 %
2nd Quarter June 6.77 % 3.29 % 0.41 % 9.57 %
1st Quarter March 2.78 % -2.7 % 6.91 % 5.82 %
FY   - 3.12 % 0.57 % -

Financial Statements
Tenet Healthcare's second quarter 2026 Revenue $ 5,628.00 millions THC's Income Statement
Tenet Healthcare's second quarter 2025 Revenue $ 5,271.00 millions Quarterly THC's Income Statement


THC Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 4.5 % -0.98 % 6.18 %
3rd Quarter September - 0.34 % 0.37 % -0.31 %
2nd Quarter June 4.84 % 0.92 % -4.94 % 1.21 %
1st Quarter March -2.88 % 2.98 % -0.2 % 0.62 %
FY (Year on Year)   - 3.12 % 0.57 % -


Back to THC Growth rate Comparisons >> Back to THC Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #25
Healthcare Sector #351
Overall #2388

Revenue Y/Y Growth Statistics
High Average Low
194.37 % 7.6 % -31.81 %
(Sep. 30, 2014)   (Sep 30 2015)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #25
Healthcare Sector #351
Overall #2388
Revenue Y/Y Growth Statistics
High Average Low
194.37 % 7.6 % -31.81 %
(Sep. 30, 2014)   (Sep 30 2015)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Tenet Healthcare's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
562.75 % 5.91 % -75.4 %
(Dec 31 2013)  


THC's II. Quarter Q/Q Revenue Comment
Tenet Healthcare Corp achieved in the II. Quarter 2026 below company average Revenue growth of 4.84% quarter on quarter, to $ 5,628.00 millions.

II. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 0.92% in the II. Quarter a year ago.

Within Healthcare Facilities industry 10 other companies have achieved higher Revenue quarter on quarter growth. While Tenet Healthcare's Revenue growth quarter on quarter, overall rank is 1108.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #11
Healthcare Sector #165
Overall #1108
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #11
Healthcare Sector #165
Overall #1108
Revenue Q/Q Growth Statistics
High Average Low
562.75 % 5.91 % -75.4 %
(Dec 31 2013)  


THC's II. Quarter Q/Q Revenue Comment
Tenet Healthcare Corp achieved in the II. Quarter 2026 below company average Revenue growth of 4.84% quarter on quarter, to $ 5,628.00 millions.

II. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 0.92% in the II. Quarter a year ago.

Within Healthcare Facilities industry 10 other companies have achieved higher Revenue quarter on quarter growth. While Tenet Healthcare's Revenue growth quarter on quarter, overall rank is 1108.


Tenet Healthcare's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 21,812.00 $ 21,455.00 $ 21,310.00 $ 20,855.00 $ 20,688.00
Y / Y Revenue Growth (TTM) 5.43 % 4.56 % 3.12 % -0.56 % -1.09 %
Year on Year Revenue Growth Overall Ranking # 2565 # 2269 # 939 # 1319 # 1489
Seqeuential Revenue Change (TTM) 1.66 % 0.68 % 2.18 % 0.81 % 0.82 %
Seq. Revenue Growth (TTM) Overall Ranking # 2388 # 2269 # 1019 # 1977 # 2031


Cumulative Revenue growth Comment
Although Tenet Healthcare's Annual Revenue growth year on year were below company's average 7.6% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 5.43% year on year, from 4.56% in Mar 31 2026.

In the Healthcare sector 370 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2269 to 2565.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 25
Healthcare Sector # 371
Overall # 2565

Revenue TTM Y/Y Growth Statistics
High Average Low
194.37 %
 7.6 %
-31.81 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 25
Sector # 351
S&P 500 # 2388
Cumulative Revenue growth Comment
Although Tenet Healthcare's Annual Revenue growth year on year were below company's average 7.6% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 5.43% year on year, from 4.56% in Mar 31 2026.

In the Healthcare sector 370 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2269 to 2565.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 25
Healthcare Sector # 371
Overall # 2565

Revenue TTM Y/Y Growth Statistics
High Average Low
194.37 %
7.6 %
-31.81 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 25
Sector # 351
S&P 500 # 2388




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
THC's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Medline Inc 11.60%$ 11.603 millions
Earth Science Tech Inc 11.56%$ 11.556 millions
Immucell Corporation11.50%$ 11.501 millions
Harrow Inc 11.26%$ 11.256 millions
Rapid Micro Biosystems Inc 10.91%$ 10.906 millions
Livanova Plc10.80%$ 10.797 millions
Cerus Corporation10.52%$ 10.517 millions
Interpace Biosciences Inc 10.33%$ 10.331 millions
Warby Parker Inc 10.25%$ 10.253 millions
Neuronetics Inc 10.25%$ 10.249 millions
Elanco Animal Health Incorporated10.23%$ 10.234 millions
Quest Diagnostics Inc10.21%$ 10.214 millions
Gilead Sciences Inc 10.18%$ 10.181 millions
Lifeloc Technologies Inc 10.16%$ 10.163 millions
Abbvie Inc 10.16%$ 10.160 millions
Concentra Group Holdings Parent Inc 10.03%$ 10.030 millions
Lemaitre Vascular Inc 10.02%$ 10.017 millions
Amneal Pharmaceuticals Inc 9.93%$ 9.934 millions
Merit Medical Systems Inc9.79%$ 9.792 millions
Idexx Laboratories Inc9.73%$ 9.728 millions
Lenz Therapeutics Inc 9.72%$ 9.720 millions
Encompass Health Corporation9.58%$ 9.584 millions
Trisalus Life Sciences Inc 9.57%$ 9.567 millions
Amgen Inc 9.53%$ 9.533 millions
Sotera Health Company9.45%$ 9.452 millions
Illumina Inc 9.44%$ 9.443 millions
Stryker Corp9.42%$ 9.415 millions
International Stem Cell Corporation9.32%$ 9.318 millions
Cytosorbents Corporation9.29%$ 9.292 millions
Resmed Inc 9.22%$ 9.222 millions


About Tenet Healthcare Revenue Growth Rates (THC), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Tenet Healthcare Corp (CIK 70318).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0000070318-26-000037
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Tenet Healthcare Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.